CHICAGO — Treatment with a single intravitreal injection of Yutiq can significantly reduce recurrence rates of noninfectious uveitis affecting the posterior segment, according to a speaker here.
“Patients with uveitis of the posterior segment who receive one fluocinolone acetonide implant throughout a 36-month period are more likely to achieve and maintain inflammation control. They are less likely for the need of systemic or local rescue therapy, and have a better chance of resolution of macular edema,” Quan Dong Nguyen, MD, MSc, said at the American Society of Retina
Uncategorized